INSP

Ban Randy

Known title: Chief Commercial OfficerCIK: 0001737127

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 14, 2026

Barclays Starts Coverage of Inspire Medical with Underweight. Barclays has begun coverage of Inspire Medical Systems and assigned an Underweight rating. The firm set a price target of $65 for the stock. This rating follows the recent analyst activity on the company. The stock is currently near its long‑term support level.

this person other insiders at INSP

Transaction History

INSP▼ Sell$414K
INSP▼ Sell$230K
INSP▼ Sell$89K
INSP▲ Buy$0
INSP▼ Sell$411K
INSP▲ Buy$1.7M
INSP▼ Sell$446K
INSP▼ Sell$179K
INSP▼ Sell$638K
INSP▼ Sell$711K
INSP▼ Sell$625K
INSP▼ Sell$110K
INSP▲ Buy$0
INSP▼ Sell$240K
INSP▼ Sell$686K
INSP▼ Sell$593K
INSP▼ Sell$467K
INSP▼ Sell$57K
INSP▼ Sell$168K
INSP▼ Sell$578K
INSP▼ Sell$170K
INSP▲ Buy$205K
INSP▲ Buy$680K
INSP▼ Sell$147K
INSP▼ Sell$316K
INSP▼ Sell$398K
INSP▼ Sell$221K
INSP▼ Sell$458K
INSP▼ Sell$1.6M
INSP▼ Sell$557K
INSP▲ Buy$129K
INSP▲ Buy$11K
INSP▲ Buy$40K
INSP▼ Sell$2.3M
INSP▲ Buy$0
INSP▲ Buy$9K
INSP▼ Sell$304K
INSP▼ Sell$837K
INSP▼ Sell$81.7M
INSP▼ Sell$235K
INSP▼ Sell$412K
INSP▲ Buy$9K
INSP▼ Sell$601K
INSP▼ Sell$654K
INSP▼ Sell$268K
INSP▼ Sell$40K
INSP▼ Sell$957K
INSP▼ Sell$1.2M
INSP▼ Sell$460K
INSP▼ Sell$152K
INSP▼ Sell$333K
INSP▼ Sell$275K
INSP▲ Buy$10K
INSP▲ Buy$7K
INSP▼ Sell$864K
INSP▲ Buy$2K
INSP▼ Sell$1.6M
INSP▲ Buy$10K
INSP▲ Buy$1K
INSP▲ Buy$726
INSP▼ Sell$340K
INSP▲ Buy$6K
INSP▲ Buy$5K
INSP▼ Sell$2.0M

We use analytics to understand how market-wall is used. No personal data is sold.